Total Medical devices industry deals worth $5.3bn were announced globally for June 2022, with the $1bn acquisition of MediFox DAN Group being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 116.9% over the previous month of $2.43bn and a drop of 57.6% when compared with the last 12-month average of $12.42bn.

In terms of number of deals, the sector saw a drop of 6.00% with 188 deals in June 2022 when compared to the last 12-month average of 200 deals.

In value terms, Europe led the activity with deals worth $2.18bn in June 2022.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Medical devices industry deals in June 2022: Top deals

The top five deals accounted for 57.3% of the overall value during June 2022.

The combined value of the top five deals stood at $3.02bn, against the overall value of $5.3bn recorded for the month.

The top five Medical devices industry deals of June 2022 tracked by GlobalData were:

1) ResMed $1bn acquisition deal with MediFox DAN Group

2) The $797.86m private equity of SPT Labtech by EQT IX Fund

3) Fleury $534.27m acquisition deal with Instituto Hermes Pardini

4) The $462m acquisition of Implantable Provider Group by Evolent Health

5) Boston Scientific $230m acquisition deal with M.I.Tech